Mitigation of hearing loss from semi-circular canal transection in pseudomonas otitis media with ciprofloxacin-dexamethasone irrigation

Otology and Neurotology

Volumn 27, Issue 2, 2006, Pages 265-269

  Shefelbine, Sarah E ^a   Young, Linda J ^a   Antonelli, Patrick J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Hearing loss; Injury; Mastoidectomy; Otitis media; Treatment

Indexed keywords

CIPROFLOXACIN; DEXAMETHASONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; AUDITORY THRESHOLD; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; EAR SURGERY; GRAM NEGATIVE INFECTION; GUINEA PIG; HEARING; HEARING LOSS; LAVAGE; MASTOID; NONHUMAN; OTITIS MEDIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEMICIRCULAR CANAL;

ANIMALS; ANTI-INFECTIVE AGENTS; AUDITORY THRESHOLD; CIPROFLOXACIN; DEXAMETHASONE; GLUCOCORTICOIDS; GUINEA PIGS; HEARING LOSS, SENSORINEURAL; IRRIGATION; MASTOID; OTITIS MEDIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEMICIRCULAR CANALS; THERAPEUTIC IRRIGATION; TREATMENT OUTCOME;

EID: 33645080177     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/01.mao.0000199758.74685.2c     Document Type: Article

References (30)

1. Palva T, Karja J, Palva A. Immediate and short-term complications of chronic ear surgery. Arch Otolaryngol 1976;102:137-9.
2. Hirsch BE, Cass SP, Sekhar LN, Wright DC. Translabyrinthine approach to skull base tumors with hearing preservation. Am J Otol 1993;14:533-4.
3. Gjuric M, Wigand ME, Hosemann W. Selective resection of semicircular canals of rabbits with preservation of hearing. Acta Otolaryngol 1992;112:907-15.
4. Antonelli PJ, Bouchard KR, Kartush JM, Kubilis, PS. Triple semicircular canal occlusion in the guinea pig. Otolaryngology - Head and Neck Surgery 1997;117:509-15.
5. Kenna MA, Bluestone CD. Microbiology of chronic suppurative otitis media in children. Ped Infect Dis 1986;5:223-5.
6. Stenvqvist M, Rask-Andersen H, Anniko M. Cochlear changes following destruction of semicircular canal in healthy and previously toxin-exposed rats. Acta Otolaryngol 1997;117:681-8.
7. Iguchi H, Anniko M. Acute effects of semicircular canal destruction on the cochlea, with and without preceding Pseudomonas aeruginosa exotoxin A treatment. Acta Otolaryngol 1998;118:511-8.
8. Falcone MT, Gajewski BJ, Antonelli PJ. Hearing loss with stapedotomy in otitis media. Otolaryngol Head Neck Surg 2003;129:666-73.
9. Yunus TM, Molina RM, Prevatt AR, Gajewski BJ, Sedwick JD, Antonelli PJ. Hearing Loss with Semicircular Canal Fistulain Exotoxin A-Deficient Pseudomonas Otitis Media. Otolaryngol Head Neck Surg 2004;130:430-36.
10. Prevatt AR, Sedwick JD, Gajewski BJ, Antonelli PJ. Hearing loss with semicircular canal transection and Pseudomonas aeruginosa otitis media. Otolaryngol Head Neck Surg 2004;131:248-52.
11. Park SN, Yeo SW. Effects of antibiotics and steroid on middle ear mucosa in rats with experimental acute otitis media. Acta Otolaryngol 2001;121:808-12.
12. Takeuchi N, Anniko M. Dexamethasone modifies the effect of Pseudomonas aeruginosa exotoxin A on hearing. Acta Otolaryngol 2000;120:363-8.
13. Kawana M, Kawana C, Giebink GS. Penicillin treatment accelerates middle ear inflammation in experimental pneuomococcal otitis media. Infect Immun 1992;60:1908-12.
14. Lee JC, Remtulla RA, Stevens GR, Zhang M, Antonelli PJ. Preoperative antibiotic and steroid therapy and hearing loss caused by semicircular canal transection in pseudomonas otitis media. Otolaryngol Head Neck Surg 2005;132:896-901.
15. Jackson CG. Antimicrobial prophylaxis in ear surgery. Laryngoscope 1988;98:1116-23.
16. Alper CM, Dohar JE, Gulhan M, Ozunlu A, Bagger-Sjobak D, Hebda PA, Swarts JD. Treatment of chronic suppurative otitis media with topical tobramycin and dexamethasone. Arch Otolaryngol Head Neck Surg 2000;126:165-73.
17. Gananca MM, Albernaz PLM. Topical use of tobramycin, gentamycin, neomycin + polymyxin B, dexamethasone, and lidocaine in the treatment of otitis. In Myers E (editor), New Dimensions in Otorhinolaryngology - Head and Neck Surgery, Vol 2. Elsevier; Amsterdam 1985:237-238.
18. Roland PS, Kreisler LS, Reese B, Anon JB, Lanier B, Conroy PJ, et al. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2004;133:40-6.
19. Roland PS, Dohar JE, Lanier BJ, et al. Topical ciprofloxacin/ dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes. Otolaryngol Head Neck Surg 2004;130:736-41.
20. Roland PS, Anon JB, Moe RD, et al. Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Laryngoscope 2003;113:2116-22.
21. Brownlee RE, Hulka GF, Prazma J, Pillsbury HC 3rd. Ciprofloxacin. Use as a topical otic preparation. Arch Otolaryngol Head Neck Surg 1992;118:392-6.
22. Russell PT, Church CA, Jinn TH, Kim DJ, John EO, Jung TT. Effects of common topical otic preparations on the morphology of isolated cochlear outer hair cells. Acta Otolaryngol 2001;121:135-9.
23. Park SK, Choi D, Russell P, John EO, Jung TT. Protective effect of corticosteroid against the cytotoxicity of aminoglycoside otic drops on isolated cochlear outer hair cells. Laryngoscope 2004 Apr;114:768-71.
24. Wormald PJ, Nilssen EL. Do the complications of mastoid surgery differ from those of the disease? Clin Otolaryngol 1997;22:355-7.
25. Kartush JM, Cannon SC, Bojrab DI, Graham MD, Schmaltz S, Kemink JL. Use of bacitracin for neurotologic surgery. Laryngoscope 1988;98:1050-4.
26. Malaty J, Lee JC, Zhang M, Stevens G, Antonelli PJ. Hearing Loss And Extent of Labyrinthine Injury in Pseudomonas Otitis Media. Otolaryngol Head Neck Surg 2005;132:25-9.
27. Morizono T, Giebink GS, Paparella MM, Sikora MA, Shea D. Sensorineural hearing loss in experimental purulent otitis media due to Streptococcus pneumoniae. Arch Otolaryngol 1985;111:794-8.
28. Maeta M, Anniko M. Protective effect of brain-derived neurotrophic factor against the ototoxicity of Pseudomonas aeruginosa exotoxin A. Acta Otolaryngol 2003;123:14-9.
29. Juhn SK, Tolan CJ, Antonelli PJ, Giebink GS, Goycoolea MV. The significance of experimental animal studies in otitis media. Otolaryngol Clin North Am 1991;24:813-27.
30. Mufson MA. Streptococcus pneumoniae. In: Mandel GL, Douglas RG, Bennett JE, editors. Principles and practice of infectious disease, 3rd ed. New York: Churchill Livingstone; 1990:1539-50.